Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you use HRT gel alongside Mounjaro (tirzepatide), the core question is whether one affects how well the other works. The short answer: transdermal HRT — gels, patches and sprays applied to the skin — is generally the form NHS England recommends considering while on tirzepatide, because it bypasses the digestive system that Mounjaro slows down. That makes this a decision worth discussing with your prescriber before you change anything. These are prescription-only medicines, and what suits you depends on your full clinical picture, not a general rule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing how quickly your stomach empties into the small intestine. For most purposes this is a feature, not a side effect: it contributes to the sustained fullness that helps with weight management. But that same slowing affects the absorption of anything you swallow. Oral tablets rely on a reasonably predictable transit through the gut, and when that transit is delayed or altered, the amount of medicine reaching your bloodstream can vary.
HRT gel sidesteps this entirely. Applied to the skin (usually the inner forearm or thigh) oestradiol from a transdermal gel crosses directly through the skin into the bloodstream. The gut plays no part. This is why the NHS England guidance on weight-management injections specifically mentions considering transdermal HRT for women taking tirzepatide. The same logic applies to patches and sprays that work the same way.
This is not a warning against oral HRT, and it is not a new contraindication. It is practical pharmacology: when a medicine's absorption might be affected by something else you are taking, choosing a different delivery route removes that variable. For many women, a gel or patch is already their preferred form; for others, it is a worthwhile conversation to have at their next HRT review. The key word is considering, not switching urgently and without guidance.
Oestrogen is only part of the picture. Women with a uterus need progesterone alongside oestrogen to protect the uterine lining. Some forms are oral micronised progesterone (Utrogestan is a common example); others use a levonorgestrel-releasing intrauterine system; transdermal combined patches carry both hormones together.
The absorption concern applies most clearly to oral progesterone tablets, for the same reason it applies to any oral medicine taken alongside Mounjaro. An intrauterine system releases progesterone locally and has no absorption question at all. Transdermal combined patches, like transdermal oestrogen gels, bypass the gut completely.
None of this means your current oral progesterone is failing you, individual responses vary considerably, and the clinical evidence on exactly how much Mounjaro alters oral HRT absorption in real-world use is still developing. What it does mean is that the interaction between Mounjaro and HRT is worth raising with both your weight-management prescriber and the clinician who manages your HRT. They may want to check your hormone levels, adjust your formulation, or simply note it on your record. Worth raising.
If you are already using HRT gel when you begin tirzepatide, you are in a straightforward position. Transdermal oestradiol is already the form NHS England considers appropriate alongside Mounjaro, so there is typically nothing to change from an absorption standpoint. You can read more about taking Mounjaro with HRT in full, including what the clinical guidance actually says.
A few practical points are still worth noting. First, injecting Mounjaro and applying HRT gel at different body sites on the same day is fine; there is no topical interaction between the two. Second, Mounjaro is injected once a week into the abdomen, thigh or upper arm, the gel sites (inner forearm, thigh) can simply be kept separate. Third, if you are also using oral contraception, NHS England's guidance advises adding a non-oral contraceptive method for the first four weeks of tirzepatide and for four weeks after each dose increase, because pill absorption may be reduced. That advice is specifically about contraception, not HRT, but it illustrates the same underlying principle.
Your Mounjaro pen arrives in plain, unbranded packaging via DPD with tracking you can follow on your phone, it goes straight into the fridge on arrival, typically next to whatever you already keep there. Separately, our dedicated page on HRT and tirzepatide covers how these two treatments sit alongside each other, and your HRT gel routine stays exactly as prescribed until your clinician says otherwise.
The decision about whether to continue your current HRT formulation, switch to a gel if you are not already using one, or make any other adjustment is not one to make based on a webpage alone, including this one. It sits at the intersection of menopause care and weight management, and ideally involves both the person managing your HRT and the prescriber overseeing your tirzepatide.
At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, and that review includes any other medicines and conditions you declare. You can see more about our clinical team and how we approach complex cases. If you are already on tirzepatide through us and a question about your HRT has come up, reaching our aftercare team is straightforward, we are available seven days a week.
For a broader understanding of tirzepatide's evidence base, the tirzepatide overview covers its mechanism, trial results and licensed use in detail. If the question of HRT and bleeding changes is on your mind too, the dedicated page on Mounjaro and HRT bleeding addresses that specifically. And if you are thinking about starting treatment, our guide to tirzepatide shopping is a useful place to understand your options before a free consultation with our prescribers, so your full picture, including your HRT, gets considered from the outset.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.